肺炎球菌结合疫苗(PCV7和PCV13)对意大利儿童侵袭性肺炎球菌疾病的影响及肺炎球菌种群结构演变分析
研究纳入意大利5个地区2008-2014年5岁以下儿童侵袭性肺炎球菌疾病(IPD)监测病例,评估PCV7和PCV13接种对IPD发病率、血清型分布及抗生素耐药的影响。期间总体IPD发病率从7.8例/10万降至3.0例/10万(下降61%,P<0.001),但非疫苗血清型IPD上升,2013-2014年成为最常见类型。
要点
- 总体IPD发病率从2008年7.8例/10万降至2014年3.0例/10万(下降61%,P<0.001)。
- PCV7型IPD从2.92降至0.13例/10万(下降95%,P<0.001),PCV13非PCV7型从3.2降至0.89例/10万(下降72%,P=0.008)。
- 非疫苗血清型IPD上升,2014年以24F和12F最常见;青霉素耐药从14%升至23%,红霉素耐药从38%降至27%。
核心结论
- 两种PCV均使儿童疫苗相关IPD发病率大幅下降,但非疫苗血清型IPD增加并在最后两年成为最常见类型。
- 持续监测是监测儿童IPD肺炎球菌种群演变的必要工具。
研究设计与样本
- 纳入意大利5个地区(Emilia-Romagna、Lombardia、A. P. Bolzano、A. P. Trento和Piemonte)2008-2014年全国监测系统报告的5岁以下儿童全部IPD病例。
- 对肺炎球菌分离株按标准方法进行血清分型、抗生素敏感性试验和克隆分析。
主要发现
- 总体IPD发病率从2008年7.8例/10万居民降至2014年3.0例/10万(下降61%,P<0.001)。
- PCV7型IPD从2008年2.92例/10万降至2014年0.13例/10万(下降95%,P<0.001)。
- PCV13非PCV7型IPD从2008年3.2例/10万降至2014年0.89例/10万(下降72%,P=0.008)。
- 非疫苗血清型IPD随时间增加,2013-2014年比PCV13血清型IPD更常见;2014年新出现的非疫苗血清型24F和12F最常见。
- 青霉素耐药从2008年14%升至2014年23%,红霉素耐药从2008年38%降至2014年27%;2008年PCV13血清型是抗生素耐药主要责任者,随后非疫苗血清型所致耐药增加,主要因已有克隆扩增。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The use of PCV7 for children immunization was gradually implemented in the Italian regions starting from 2006 and was replaced by PCV13 in 2010-2011. In this study we aimed to assess the PCV impact on invasive pneumococcal diseases (IPD) incidence, serotype distribution and antibiotic resistance in Italian children under 5years old. METHODS: All IPD cases in children from 5 Italian regions (Emilia-Romagna, Lombardia, A. P. Bolzano, A. P. Trento, and Piemonte) reported through the nationwide surveillance system during 2008-2014 were included in this study. Pneumococcal isolates were subjected to serotyping, antibiotic susceptibility testing, and clonal analysis according to standard methods. RESULTS: During the study period overall IPD incidence decreased from 7.8 cases/100,000 inhabitants in 2008 to 3.0 cases/100,000 in 2014 (61% decrease, P<0.001). In particular, from 2008 to 2014, PCV7-type IPD decreased from 2.92 to 0.13 cases/100,000 inhabitants (95% decrease, P<0.001) while PCV13-non-PCV7 type IPD decreased from 3.2 to 0.89 cases/100,000 inhabitants (72% decrease, P=0.008). Conversely, non-vaccine serotype (NVS) IPD increased overtime, becoming more common than PCV13 serotype IPD in 2013-2014. Emergent NVS 24F and 12F were the most prevalent in 2014. Antibiotic resistance testing revealed an overall increasing trend in penicillin resistance, from 14% in 2008 to 23% in 2014. Erythromycin resistance showed a downward trend, from 38% in 2008 to 27% in 2014. While in 2008 PCV13 serotypes were the major responsible for antibiotic resistance, during the following years antimicrobial resistance due to NVS increased, mainly as a result of expansion of pre-existing clones. CONCLUSIONS: Both PCVs led to a substantial decrease in vaccine-related IPD incidence in the children population. However NVS-related IPD increased, becoming the most prevalent in the last two-years period. Continuous surveillance is an essential tool to monitor evolution of pneumococcal population causing IPD in children.
引用
- Camilli R, D'Ambrosio F, Del Grosso M, et al. Impact of pneumococcal conjugate vaccine (PCV7 and PCV13) on pneumococcal invasive diseases in Italian children and insight into evolution of pneumococcal population structure. Vaccine. 2017. PMID: 28716556. doi:10.1016/j.vaccine.2017.07.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。